White skin, vitamin D, other phenotype traits

http://www.sciencemag.org/news/2015/04/how-europeans-evolved-white-skin

Diet transition and diabetes

http://macrofour.com/nyungar-diabetes-australian-dietary-genocide

Why health authorities failed and we continue to fail

http://observer.com/2017/02/health-recommendations-wrong-saturated-fat-sodium-intake/

Risky association in junk food: trans fats and high GI products

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0016268

https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/div-classtitleassociation-between-carbohydrate-nutrition-and-prevalence-of-depressive-symptoms-in-older-adultsdiv/BB3911CDF1A1D94ACEFA0A90C5A8D20F

http://www.nutraingredients.com/Research/High-GI-carb-intake-may-trigger-a-depressive-low-study-finds/?utm_source=Newsletter_Subject&utm_medium=email&utm_campaign=Newsletter%2BSubject&c=dC5HnbRQjqnNF8RlQ1LeU%2FLajDydoHsY

https://www.ncbi.nlm.nih.gov/pubmed/22791180

http://ajcn.nutrition.org/content/early/2015/06/24/ajcn.114.103846.abstract

Evidence for efficiency of daily exposition to the sun or sun light source or intake of vitamin D3

GrassRootsHealth

http://www.bmj.com/content/356/bmj.i6583

http://www.foodmanufacture.co.uk/Ingredients/Vitamin-D-cold-and-flu-study-link-divides-scientists/?utm_source=Newsletter_Subject&utm_medium=email&utm_campaign=Newsletter%2BSubject&c=dC5HnbRQjqmLldPh8taGdocbYZm7sM2e

Total body exercise

http://madame.lefigaro.fr/bien-etre/quest-ce-que-le-top-body-challenge-090217-129606

About trans fatty acids

http://m.ajcn.nutrition.org/content/102/6/1339

http://m.ajcn.nutrition.org/content/102/6/1301.long?view=long&pmid=26561633

http://m.advances.nutrition.org/content/2/4/332.full

$71 billion of food stamps

https://www.wsj.com/articles/congress-debates-use-of-food-stamps-to-buy-junk-food-1487282084

Do you drink alcohol

http://www.businessinsider.fr/us/evolutionary-reason-people-drink-robert-dudley-drunken-monkey-hypothesis-2017-2/?utm_content=buffer3ffa8&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer-ti

Personalised nutrition

"Genetic drift, gut microbiota (both composition and functionality) and environmental factors (diet, lifestyle, etc.) is a complex cocktail of interplaying actors behind the interindividual variability observed in clinical trials, not only with drugs but also with dietary compounds. UM clustering suggests a different individuals’ cardiovascular risk pattern and also a personalised effect of ellagitannin-containing foods such as pomegranate, probably associated to specific gut microbial communities, which could explain the lack of consensus about their benefits. Therefore, clinical trials with foods or dietary compounds should take into account the large inherent interindividual variability, which might be behind the scarce number of accepted health claims by the EFSA in relation to dietary polyphenols and other phytochemicals"

Mol Nutr Food Res. 2016 Nov 23. doi: 10.1002/mnfr.201600830. [Epub ahead of print]

Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomised clinical trial.

González-Sarrías A1, García-Villalba R1, Romo-Vaquero M1, Alasalvar C2, Örem A3, Zafrilla P4, Tomás-Barberán FA1, Selma MV1, Espín JC1.

Author information

Abstract

SCOPE:

The pomegranate lipid-lowering properties remain controversial, probably due to the interindividual variability in polyphenol (ellagitannins) metabolism.

OBJECTIVE:

We aimed at investigating whether the microbial-derived ellagitannin-metabolizing phenotypes, i.e. urolithin metabotypes A, (UM-A), B (UM-B) and 0 (UM-0), influence the effects of pomegranate extract (PE) consumption on eighteen cardiovascular risk biomarkers in healthy overweight-obese individuals.

METHODS AND RESULTS:

A double-blind, cross-over, dose-response, randomised, placebo-controlled trial was conducted. The study (POMEcardio) consisted of 2 test-phases (dose-1 and dose-2, lasting 3 weeks each) and a 3-week washout period between each phase. Forty nine participants (BMI>27 kg/m2 ) daily consumed one (dose-1, 160 mg phenolics/day) or four (dose-2, 640 mg phenolics/day) PE or placebo capsules. Notably, UM-B individuals showed the highest baseline cardiovascular risk. After dose-2, total-cholesterol (-15.5±3.7%), LDL-cholesterol (-14.9±2.1%), small-LDL-cholesterol (-47±7%), non-HDL-cholesterol (-11.3±2.5%), apolipoprotein-B (-12±2.2%) and oxidised-LDL-cholesterol (-24±2.5%) dose-dependently decreased (P<0 .05="" abstracttext="" and="" became="" but="" consumption.="" correlated="" effects="" following="" gordonibacter="" in="" increase="" levels.="" non-producers="" of="" only="" partially="" pe="" producers="" production="" subjects.="" the="" these="" three="" um-b="" urolithin="" were="" with="">

CONCLUSIONS:

Urolithin metabotype (UM) clustering suggests a personalised effect of ellagitannin-containing foods and could explain the controversial pomegranate benefits. Research on the specific role of urolithins and the microbiota associated to each UM is warranted. This article is protected by copyright. All rights reserved.

This article is protected by copyright. All rights reserved.

KEYWORDS:

Cardiometabolic; EFSA; Gut microbiota; Metabotype; Urolithins

Vitamin D latest chart

http://grassrootshealth.net/media/images/chart-serum-level-intake-5-by-3-ngmla-both-charts-single.pdf

NAD+ riboside

http://alivebynature.com/about-niagen/

The renaissance of fat

https://medium.com/@davidludwigmd/adapting-to-fat-on-a-low-carb-diet-bfd0cd314e4e#.gi8j1imyv

PFAS

http://www.sciencedirect.com/science/article/pii/S004565351400678X

Actually we don't need them